95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF
#302SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS
#303HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
#304SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE
#305PYRIDAZINONES AS PARP7 INHIBITORS
#306ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF AND INSECTICIDAL AGENT CONTAINING THE COMPOUND AND METHOD FOR USING SAME
#307CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME
#308PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS
#309SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#310PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS
#3113-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES
#312HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME
#313Inhibitors of Menin-MLL Interaction
#314CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS
#315SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS
#316SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS
#317HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS
#318DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#319BICYCLIC FUSED RING DERIVATIVE OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#320CARDIAC SARCOMERE INHIBITORS
#321ANTIVIRAL COMPOUNDS
#322Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof
#323TLR MODULATOR AND USE THEREOF
#324ERBB/BTK INHIBITORS
#325SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF
#326COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS
#327DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
#328Deuterated Antiviral Compounds
#329Synthesis of MEK7 Inhibitors and methods of Use Thereof
#330PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES
#331HIV INHIBITOR COMPOUNDS
#332INHIBITORS OF APOL1 AND METHODS OF USING SAME
#333AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
#334COMPOUNDS AND USES THEREOF
#335COMPOUNDS AND USES THEREOF
#336COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS
#337COMPOUNDS, COMPOSITIONS, AND METHODS
#338ANTIMALARIAL HEXAHYDROPYRIMIDINE DERIVATIVES
#339KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
#340EGFR INHIBITORS AND METHODS OF USE THEREOF
#341TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
#342COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF
#343HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#344QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF
#345APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#346PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF
#347MASP-2 INHIBITORS AND METHODS OF USE
#348CRYSTALLINE FORM OF N-(2-CHLORO-3-((5-CHLORO-3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)AMINO)-4-FLUOROPHENYL)-3-FLUOROAZETIDINE-1-SULFONAMIDE
#349PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS
#350PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS
#351NOVEL CAPSID ASSEMBLY INHIBITORS
#352NOVEL ANTI-DEPRESSANT AND NEUROPLASTIC AGENTS AND THERAPEUTIC USES THEREOF
#353NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY
#354METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#355PSMA Imaging Agents
#356HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS
#357FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#358INHIBITORS OF TYK2
#359CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS
#360ISOINDOLINES AS PMS2 INHIBITORS
#361INHIBITORS OF TYK2
#362NOVEL SUBSTITUTED PYRAZINE-CARBOXAMIDE DERIVATIVES
#363BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6
#364P2X4 RECEPTOR ANTAGONIST
#365PSMA Imaging Agents
#366CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
#367HMOX1 INDUCERS
#368PARP INHIBITORS FOR TREATING CANCER AND ASTHMA
#369ORGANIC COMPOUNDS
#370CYANO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#371COMPOUNDS TARGETING MUTANT OF P53
#372MODULATORS OF PROTEIN KINASES
#373AMINE BASED MATRIPTASE 2 INHIBITORS AND USES THEREOF
#374Methods for treating cancer
#375SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
#376RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF
#377MASP-2 INHIBITORS AND METHODS OF USE
#378SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4
#379DISULFIDE COMPOUND, POLYSULFIDE COMPOUND, AND USE THEREOF
#380DIHYDROPYRIMIDINE BASED COMPOUND, PREPARATION METHOD THEREFOR AND USE OF THEREOF
#381AUTOTAXIN-INHIBITORS
#382Substituted Quinoxalines
#383PHARMACEUTICAL USE AND PREPARATION METHOD FOR SUBSTITUTED HETEROARYL PHTHALAZINE DERIVATIVE
#384HETEROARYL DERIVATIVE AND USE THEREOF
#385SMALL MOLECULE BTK DEGRADERS AND METHODS OF USE THEREOF
#386BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#387PYRIMIDINEDIONE COMPOUNDS
#388NITROGEN-CONTAINING HETEROCYCLIC PYRIDINE COMPOUND
#3895-HALOALKOXY-PYRIMIDINE COMPOUNDS AS HERBICIDES
#390IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE
#391NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#392Bcl-2 Inhibitors
#393SULFOXIMINE COMPOUND AND USE THEREOF
#394BENZIMIDAZOLES AS MODULATORS OF IL-17
#395INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS
#396COMPOUND AS TYK2/JAK1 PSEUDOKINASE DOMAIN INHIBITOR, AND SYNTHESIS AND USE METHODS
#397Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof
#398METHODS AND COMPOSITIONS FOR TARGETING PD-L1
#399QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#400Compounds for the Treatment of Alzheimer's Disease
#401PHENYL ACETAMIDE BASED IL-17A MODULATORS AND USES THEREOF
#402PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE
#403PIKfyve Inhibitors
#404BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
#405ROCK2 INHIBITORS AND USES THEREOF
#406OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
#407CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE
#408SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
#409PYRIDAZINONE AND METHODS OF USE THEREOF
#410AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#411JAK2 INHIBITORS AND METHODS OF USE THEREOF
#412RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#413CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
#414AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE
#415GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF
#416MODULATORS OF A POTASSIUM CHANNEL AND OF TRPV1 CHANNEL AND USES THEREOF
#417PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF
#418TRANSCRIPTIONAL ENHANCED ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF
#419Glucose Uptake Inhibitors
#420THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#421STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-2-(2,2-DIMETHYLPROPYL)-1H-1,3-BENZODIAZOL-5-YL}SULFONYL)AZETIDIN-1-YL]ETHAN-1-OL
#422NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
#423NOVEL PARP7 INHIBITOR AND USE THEREOF
#424ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS
#425INDOLINE COMPOUNDS FOR INHIBITING KIF18A
#426COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING
#427SOLID-STATE FORMS OF 2-(3-(4-(1H-INDAZOL-5-YLAMINO)QUINAZOLIN-2-YL)PHENOXY)-N-ISOPROPYLACETAMIDE METHANE SULFONIC ACID SALT
#4281-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- I - YL) UREAS AS P38 MAPKINASE INHIBITORS
#429SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES
#430PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
#431PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
#432IL4I1 INHIBITORS AND METHODS OF USE
#433SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#434PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR
#435PARP7 INHIBITOR AND USE THEREOF
#436METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE
#437SULFUR/PHOSPHORUS-CONTAINING ARYL COMPOUND AND APPLICATION THEREOF
#438SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)
#439FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF
#440TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS
#441BTK INHIBITORS
#442AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#443Covalent Inhibitors As Antiviral Agents
#444A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13
#445Compounds useful for treating gastrointestinal tract disorders
#446SUBSTITUTED HETEROCYCLIC COMPOUNDS
#447SULFONAMIDE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#448HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
#449APOL1 INHIBITORS AND METHODS OF USE
#450INDAZOLE COMPOUNDS
#451NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR
#452Jak Inhibitor With High Oral Bioavailability
#453CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES
#454Quinazoline Compounds and Uses
#455PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF
#456HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#457PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR
#458ADDITIVE FOR IMPARTING ULTRAVIOLET ABSORBENCY AND/OR HIGH REFRACTIVE INDEX TO MATRIX, AND RESIN MEMBER USING SAME
#459CDK2 INHIBITORS
#460TREATMENT OF LIVER DISORDERS WITH A THR-ß AGONIST
#461NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR
#462PROTEASE INHIBITORS AND METHODS OF USE
#463TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS
#464PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#465(4-(6-((2-OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)PHENYL)(IMINO)(METHYL)-LAMBDA6- SULFANONE DERIVATIVES AND SIMILAR COMPOUNDS AS MUSCARINIC ACETYLCHOLINE RECEPTOR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
#466Compounds and radioligands for targeting neurotensin receptor and uses thereof
#467CRYSTAL FORM OF PYRIMIDINE DERIVATIVE AND PREPARATION METHOD THEREFOR
#468SALT OF SELECTIVE FGFR4 INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#469KETOAMIDE DERIVATIVE AND APPLICATION THEREOF
#470MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#471PHENOL RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#472COMPOUNDS FOR THE TREATMENT OF SARS
#473INDOLE COMPOUNDS AND METHODS OF USE
#474NOVEL BENZIMIDAZOLE DERIVATIVE
#475NOVEL DIPHENAZINE COMPOUND, AND USE THEREOF FOR PREVENTING OR TREATING CANCER OR NEUROINFLAMMATORY DISEASES
#476DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE
#477Hydrazide containing nuclear transport modulators and uses thereof
#478COMPOUNDS, DEVICES, AND USES THEREOF
#479ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#480IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE
#481POLO LIKE KINASE 4 INHIBITORS
#482INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#483COMPOUNDS HAVING N-ARYLPYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC AGENTS
#4843-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES
#485PEPTIDE NUCLEIC ACIDS, SYNTHESIS, AND USES THEREOF
#486QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2
#487NEW SELECTIVE ANGIOTENSIN II COMPOUNDS
#488Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease
#489INHIBITORS OF NLRP3
#490QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#491SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#492SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF
#493MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
#494COMPOSITIONS AND METHODS FOR INHIBITING KRAS
#495Anilino-Pyrazole Derivatives, Compositions and Methods Thereof
#496AMINO HETEROARYL COMPOUNDS AND COMPOSITIONS
#497MULTIFACETED APPROACH TO NOVEL INTERLEUKIN-6 INHIBITORS
#498HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
#499INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#500QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND
#501ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS
#502COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF
#503TRIAZOLE DERIVATIVES WITH ANTIFUNGAL ACTIVITY
#504EBNA1 Inhibitors and Methods Using Same
#505TEAD INHIBITORS
#506PRODRUGS OF 6-DIAZO-5-OXO-L-NORLEUCINE
#507Papain-like protease (PLpro) inhibitors
#508COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
#509INDOLE COMPOUNDS AND METHODS OF USE
#510PROTEASE INHIBITORS AND METHODS OF USE
#511BACTERIAL EFFLUX PUMP INHIBITORS
#512ALLYL-CONTAINING BISPHENOL RESIN
#513SUBSTITUTED TRIAZINE COMPOUND
#514PHTHALAZINONE DERIVATES AS NLRP3 INFLAMMASOME INHIBITORS
#515SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
#516N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
#517PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT
#518INHIBITORS OF PLASMA KALLIKREIN
#519COMPOUNDS AND METHODS FOR MODULATING SPLICING
#520PHARMACEUTICAL COMPOUND
#521SARS-COV-2 MPRO INHIBITOR COMPOUNDS
#522MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
#523SUBSTITUTED FUSED BICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF
#524FUNCTIONALIZED MATERIALS AND COMPOUNDS
#5256-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES
#526Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox Inhibition
#527POLYMORPHS OF SELINEXOR
#528ULK1/2 INHIBITORS AND THEIR USE THEREOF
#529WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE
#530AURISTATIN LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#531Light-Emitting Element, Display Device, Electronic Device, and Lighting Device
#532QUINAZOLINE-4(3H)-ONE DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#533NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#534DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
#535SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS
#536SOLID FORMS OF (3R)-N-[2-CYANO-4-FLUORO-3-(3-METHYL-4-OXO-QUINAZOLIN-6-YL)OXY-PHENYL]-3-FLUORO-PYRROLIDINE-1-SULFONAMIDE
#537KRAS INHIBITORS
#538ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
#539ACORAMIDIS ANALOGS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING
#540APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION
#541Inhibitors of receptor interacting protein kinase I for the treatment of disease
#542INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF
#543SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
#544SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY
#545CDK INHIBITORS AND METHODS OF USE THEREOF
#546INHIBITORS OF LRRK2 KINASE
#547Thyroid hormone receptor agonists and use thereof
#548CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
#549PYRIDAZINONES AS PARP7 INHIBITORS
#550Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase
#551Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics
#552SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#553METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH HYPERMINERALIZATION
#554INHIBITORS OF RAF KINASES
#555NOVEL SUBSTITUTED PYRAZINE-CARBOXAMIDE DERIVATIVES
#556ANTI-VIRAL COMPOUNDS
#557HETEROCYCLIC COMPOUND AS TYK2 PSEUDOKINASE DOMAIN INHIBITOR, SYNTHETIC METHOD, AND USE
#558Anti-cancer nuclear hormone receptor-targeting compounds
#559Theramutein modultors
#560OX2R Compounds
#561HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#562Pyrazolopyrimidine compounds as kinase Inhibitors
#563SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES
#564CDK2 INHIBITORS AND USES THEREOF
#565Small Molecule Compound
#566KINASE MODULATORS AND METHODS OF USE THEREOF
#567METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE THEREOF
#568SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#569NOVEL PYRIMIDINE DERIVATIVE SHOWING INHIBITION EFFECT ON GROWTH OF CANCER CELLS
#570COMPOUND, METHOD FOR PRODUCING AND METHOD FOR STORING COMPOUND, METHOD FOR PRODUCING TARGETING AGENT, AND COMPOSITION
#571COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME
#572BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS
#573SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE
#574Pyrimidine compound as JAK kinase inhibitor
#575RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#576RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF
#577BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
#578PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS
#579DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#580Compounds, Compositions and Methods
#581ULK INHIBITORS AND METHODS OF USE THEREOF
#582CARBOXAMIDE COMPOUNDS AND USES THEREOF
#583NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS
#5845-membered heteroaryl carboxamide compounds for treatment of HBV
#585Quaternary indazole glucocorticoid receptor antagonists
#586PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS
#587NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES
#588Human plasma kallikrein inhibitors
#589Human plasma kallikrein inhibitors
#590Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof
#591SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
#592METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF
#593DISCRETE PEG CONSTRUCTS
#594CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS
#595NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT
#596HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS
#597PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS
#598FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
#599INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#600SUBSTITUTED PYRAZOLYL COMPOUNDS AS MALT-1 INHIBITORS